Every 8-K that Defiance KSM Israel 120 ETF (ISRL) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ISRL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ISRL filings page.
Israel Acquisitions Corp filed an 8-K describing a sixth amendment to its Business Combination Agreement with Gadfin Ltd. and Gadfin Regev Holdings Ltd. The amendment, signed on May 31, 2026, extends the agreement’s termination date to June 15, 2026, while leaving all other termination rights unchanged.
The filing notes that the full text of Amendment No. 6 is provided as an exhibit, alongside references to the original agreement and prior five amendments, underscoring that the parties continue to work under the existing deal structure with a short additional window to complete the transaction.
Israel Acquisitions Corp disclosed that it entered into a fifth amendment to its Business Combination Agreement with Gadfin Ltd. and Gadfin Regev Holdings Ltd. on May 15, 2026. The amendment extends the agreement’s termination date to May 31, 2026, while leaving all other termination rights unchanged.
The filing also lists the prior Business Combination Agreement dated January 26, 2025 and four earlier amendments from July 2, 2025, December 31, 2025, March 13, 2026, and April 15, 2026, highlighting an ongoing effort to complete the planned transaction with Gadfin.
Israel Acquisitions Corp entered a fourth amendment to its Business Combination Agreement with Gadfin Ltd. and Gadfin Regev Holdings Ltd. on April 15, 2026. The amendment revises Section 7.1(d) to extend the agreement’s termination date to May 15, 2026, with all other termination rights unchanged.
Israel Acquisitions Corp entered into a Third Amendment to its business combination agreement with Gadfin Ltd. and Gadfin Regev Holdings Ltd. On March 13, 2026, the parties agreed to revise Section 7.1(d) of the agreement to extend the deal’s termination date to April 15, 2026, giving them additional time to close or otherwise resolve the proposed business combination. All other termination rights in the original and prior amended agreements remain in place. The new amendment is filed as Exhibit 2.4 alongside the original January 26, 2025 agreement and the first two amendments.
Israel Acquisitions Corp amended a prior current report to describe two December 31, 2025 actions tied to its planned business combination with Gadfin Ltd..
First, the company and its sponsor signed a waiver to their Administrative Services Agreement. The sponsor agreed to forgo a $10,000 per month administrative fee that would have been paid until a business combination or liquidation, and waived $240,000 of administrative fees that had already accrued.
Second, Israel Acquisitions Corp, Gadfin, and Gadfin Regev Holdings Ltd. executed a second amendment to their business combination agreement. This amendment revised the termination provision to extend the deal’s outside date to March 16, 2026 and removed earlier automatic extension language, while keeping all other termination rights in place. The full waiver and amendment texts are filed as exhibits.
Israel Acquisitions Corp reports that its securities are being delisted from Nasdaq after failing to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A), which requires a minimum market value of listed securities of $50 million. Trading was suspended on December 4, 2025 and moved to the Pink Limited Market, and Nasdaq filed Form 25 on January 21, 2026, with the delisting becoming effective 10 days later. Deregistration of the common stock under Section 12(b) will become effective 90 days after that filing, or earlier if determined by the SEC.
Shareholders approved extending the deadline to complete an initial business combination from January 18, 2026 up to 12 one‑month extensions to January 18, 2027. Each extension requires a deposit into the trust account of the lesser of $5,000 or $0.05 per public share, in exchange for a non‑interest‑bearing promissory note. In connection with the vote, holders of 295,860 Class A shares redeemed for an estimated $3,683,115.04 (about $12.45 per share), leaving an estimated $6,250,216.09 in the trust account and 6,056,239 ordinary shares outstanding.
Israel Acquisitions Corp reported that Nasdaq plans to delist all of its publicly traded securities. According to a Nasdaq press release issued under Nasdaq Listing Rule 5830 and Exchange Act Rule 12d2-2, Nasdaq intends to delist the company’s Class A ordinary shares, its units (each consisting of one Class A ordinary share and one redeemable warrant), and its redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share.
The delisting will become effective ten days after Nasdaq files a Form 25 to remove the securities from listing. The Nasdaq press release is being furnished as an exhibit and is not deemed filed for liability purposes under the Exchange Act.
Israel Acquisitions Corp entered into a waiver with its sponsor that eliminates certain administrative service fees. The sponsor agreed to waive the $10,000 per month it was entitled to receive until the company completes an initial business combination or is liquidated, as well as $240,000 of administrative fees that had already accrued.
This change reduces the company’s ongoing overhead and forgives past amounts owed to its sponsor, helping preserve cash within the special purpose acquisition company structure.
Israel Acquisitions Corp (ISRL) reported that on November 3, 2025 it finalized a corporate presentation for use with potential investors and made it available as Exhibit 99.1. The materials are being filed pursuant to Rule 425 of the Securities Act and are incorporated by reference.
The company notes that any website references in the materials are inactive textual references and not part of the filing. The presentation and this report include forward-looking statements subject to risks described in the company’s SEC reports. ISRL’s securities trade on Nasdaq: ISRLU (units), ISRL (Class A ordinary shares), and ISRLW (redeemable warrants).
Israel Acquisitions Corp (ISRL) disclosed a Letter Agreement with Gadfin and an Advisory Agreement with BTIG tied to ISRL’s proposed business combination with Gadfin. BTIG will provide strategic and capital markets advisory services and, as compensation, receive $500,000 in cash (payable from the trust) and 100,000 Class A shares of ISRL immediately prior to closing, which will be exchanged for 100,000 NewPubco shares valued at $10.00 per share upon consummation.
In exchange, BTIG waived its deferred underwriting commission, conditioned on payment of the advisory fee and closing. The Sponsor agreed to forfeit additional ISRL shares equal to the number issued to BTIG. Gadfin consented to the advisory arrangement and waived its BCA termination right related to obtaining the deferred fee waiver. Before closing, NewPubco will arrange a Public Offering of Securities Insurance to cover any BTIG indemnification claims. BTIG also received a three‑year ROFR to lead the next SPAC IPO by ISRL or the Sponsor and may terminate the agreement at any time, forfeiting both the advisory fee and the deferred commission.